Publications

  1. Oommen S, Cantero Peral S, Qureshi MY, Holst KA, Burkhart HM, Hathcock MA, Kremers WK, Brandt EB, Larsen BT, Dearani JA, Edwards BS, Maleszewski JJ, Nelson TJ, Wanek Program Pre-Clinical Pipeline. Autologous Umbilical Cord Blood-Derived Mononuclear Cell Therapy Promotes Cardiac Proliferation and Adaptation in a Porcine Model of Right Ventricle Pressure Overload. Cell Transplant. 2022 Jan-Dec; 31:9636897221120434
    View PubMed
  2. Burkhart HM, Qureshi MY, Rossano JW, Cantero Peral S, O'Leary PW, Hathcock M, Kremers W, Nelson TJ, Wanek HLHS Consortium Clinical Pipeline. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections. J Thorac Cardiovasc Surg. 2019 Dec; 158(6):1614-1623. Epub 2019 Jun 07.
    View PubMed
  3. Anderson JH, Taggart NW, Edgerton SL, Cantero Peral S, Holst KA, Cetta F, Wanek Program Preclinical Pipeline. Ultrasound guided percutaneous common carotid artery access in piglets for intracoronary stem cell infusion. Lab Anim. 2018 Feb; 52 (1):88-92 Epub 2017 July 14
    View PubMed
  4. Qureshi MY, Cabalka AK, Khan SP, Hagler DJ, Haile DT, Cannon BC, Olson TM, Cantero-Peral S, Dietz AB, Radel DJ, Taggart NW, Kelle AM, Rodriguez V, Dearani JA, O'Leary PW, Wanek Program Regenerative Medicine Pipeline. Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome. Mayo Clin Proc Innov Qual Outcomes. 2017 Sep; 1 (2):185-191 Epub 2017 Aug 02
    View PubMed
  5. Cantero Peral S, Bernstein D, Nelson TJ. Regenerative medicine - from stem cell biology to clinical trials for pediatric heart failure Progress In Pediatric Cardiology. 2016 Dec; 43:87-9.
  6. Nelson TJ, Cantero Peral S. Stem Cell Therapy and Congenital Heart Disease. J Cardiovasc Dev Dis. 2016 Jul 5; 3 (3) Epub 2016 July 05
    View PubMed
  7. Oommen S, Yamada S, Cantero Peral S, Campbell KA, Bruinsma ES, Terzic A, Nelson TJ. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res Ther. 2015 Mar 26; 6:50
    View PubMed
  8. Burkhart HM, Qureshi MY, Peral SC, O'Leary PW, Olson TM, Cetta F, Nelson TJ, Wanek Program Clinical Pipeline Group. Regenerative therapy for hypoplastic left heart syndrome: first report of intraoperative intramyocardial injection of autologous umbilical-cord blood-derived cells. J Thorac Cardiovasc Surg. 2015 Mar; 149: (3)e35-7.
    View PubMed
  9. Cantero Peral S, Burkhart HM, Oommen S, Yamada S, Nyberg SL, Li X, O'Leary PW, Terzic A, Cannon BC, Nelson TJ, Wanek Program Porcine Pipeline Group. Safety and feasibility for pediatric cardiac regeneration using epicardial delivery of autologous umbilical cord blood-derived mononuclear cells established in a porcine model system. Stem Cells Transl Med. 2015 Feb; 4(2):195-206. Epub 2015 Jan 05.
    View PubMed
  10. Peral SC, Burkhart HM, Nelson TJ. Utilization of stem cells to treat congenital heart disease: hype and hope. Curr Opin Pediatr. 2014 Oct; 26(5):553-60.
    View PubMed
  11. Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem. 2011 Apr; 112: (4)1206-18.
    View PubMed
  12. Montesinos P, Sanz J, Cantero S, Lorenzo I, Martin G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martinez J, Jarque I, Salavert M, Cordoba J, Gomez L, Weiss S, Moscardo F, de la Rubia J, Larrea L, Sanz MA, Sanz GF. Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2009 Jun; 15: (6)730-40.
    View PubMed
  13. Moscardo F, Sanz J, Senent L, Cantero S, de la Rubia J, Montesinos P, Planelles D, Lorenzo I, Cervera J, Palau J, Sanz MA, Sanz GF. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies. Haematologica. 2009 Jun; 94: (6)827-32.
    View PubMed
  14. Brunstein CG, Cantero S, Cao Q, Majhail N, McClune B, Burns LJ, Tomblyn M, Miller JS, Blazar BR, McGlave PB, Weisdorf DJ, Wagner JE. Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2009 Feb; 15: (2)214-22.
    View PubMed
  15. Puig N, de la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, Martin G, Sanz G, Cantero S, Lorenzo I, Sanz MA. A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation. Int J Hematol. 2007 Aug; 86: (2)186-92.
    View PubMed
  16. Sanz J, Arriaga F, Montesinos P, Orti G, Lorenzo I, Cantero S, Puig N, Moscardo F, de la Rubia J, Sanz G, Sanz MA. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Bone Marrow Transplant. 2007 May; 39: (9)555-61.
    View PubMed
  17. de la Rubia J, Cantero S, Sanz GF, Remigia MJ, Monteagudo E, Moscardo F, Martin G, Lorenzo I, Jimenez C, Martinez J, Montesinos P, Jarque I, Sanz MA. Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution. Bone Marrow Transplant. 2005 Aug; 36: (4)325-9.
    View PubMed